why choose us

First received: December 6, 2022

Clinical Trial: Pre-approval Single-patient Expanded Access for Talazoparib (PF-06944076)

Condition: Metastatic Castration-Resistant Prostate Cancer

Study Type: Expanded Access


Official Title: Not Provided

Brief Summary: Provide pre-approval single-patient Expanded Access (Compassionate Use) of talazoparib for patients with metastatic castration-resistant prostate cancer.

Read more